US › Healthcare

Omada Health, Inc. Common Stock (OMDA)

US · Healthcare · Health Information Services

$20.18-1.61%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$78.0M
Revenue YoY
+42.0%
Net profit
$-3.0M
Profit YoY
+68.6%
EPS
$0.05
EPS estimate
$-0.04
Net margin
-3.8%

EPS came in at 0.05 against a street estimate of -0.04 — a beat of 225.0%.

Key statistics

Market cap
$1.18B
Forward P/E
666.7
P/B
5.04
Book value
$3.95
EPS (TTM)
$-0.23
52-week high
$26.91
52-week low
$10.28
50-day MA
$19.85
200-day MA
$17.05

Analyst view

with an average price target of $24.58.

Shareholding

Insiders
2.18%
Institutions
82.03%

Largest institutional holders

FundStake
Divisadero Street Capital Management, LP9.90%
Revelation Capital Management, LLC8.76%
Cigna Investments Inc5.79%
FMR Inc5.53%
NVP Associates LLC4.26%
American Century Companies Inc4.13%
BlackRock Inc3.20%
Vanguard Capital Management, LLC3.04%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Omada Health, Inc. Common Stock — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.